Skip to main content
. 2019 Oct 29;93(18):e1699–e1706. doi: 10.1212/WNL.0000000000008386

Table 3.

Total ventricle volume estimates from post hoc test between presymptomatic mutation carriers (n = 46) and noncarriers (n = 53) by time to expected symptom onset with no influential cases (n = 2) or extreme case (n = 1)

graphic file with name NEUROLOGY2018961557TT3.jpg